1. Compounding Rules Committee – Michele Weizer, PharmD
Dr. Weizer provided a report from the December 2, 2013 Compounding Rules Committee and stated that the committee is ready to give two recommendations to the Board. Dr. Weizer highlighted the two different exceptions that were discussed at the committee meeting including facility design and the cleaning of a workspace.
Dr. Weizer introduced Federal Legislation titled "HR 3204 Drug Quality and Security Act" that had recently been signed into law by the President and requested that the Board open up the office-use compounding rule to look at quantity issues as well as find any conflicts that may be present due to the new Federal legislation.
Mr. Flynn gave a high level summary of "HR 3204Drug Quality and Security Act" and gave a brief description of how this legislation could potentially affect the practice and profession of pharmacy in Florida.
Motion: by Dr. Weizer, seconded by Mrs. Glass, to open up House Bill 3204 to look at limited quantities and to look at the Board’s rule with implications from the FDA. Motion carried.
quoted from here
No comments:
Post a Comment